Literature DB >> 8990258

Assessing liver function and hyperbilirubinemia in the newborn. National Academy of Clinical Biochemistry.

P Rosenthal1.   

Abstract

In clinical practice, "liver function" is assessed by either measuring the concentration of substances produced by the hepatocyte, measuring the serum content of substances that are changed by hepatocyte damage, evaluating the serum concentrations of substances released from the cells as a result of injury, assessing the ability of the liver to perform a metabolic task such as conjugation or detoxification, or by measuring enzyme activity and substrate content of the cell and its organelles. After birth, with cessation of placental function, the neonatal liver must assume many different tasks. Distinct developmental sequences rapidly progress for numerous hepatic functions as the newborn adapts to its environment. This manuscript is an attempt to provide guidelines for the evaluation and management of the newborn infant when assessing liver function and hyperbilirubinemia. These guidelines, like all sets of guidelines, are only recommendations and do not substitute for good clinical judgment based upon the individual circumstances of each patient.

Entities:  

Mesh:

Year:  1997        PMID: 8990258

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Relationship between serum bilirubin and coagulation test results in 1-month-old infants.

Authors:  Secil Aydinoz
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

2.  Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.

Authors:  Gareth J Veal; Julie Errington; Jairam Sastry; Julia Chisholm; Penelope Brock; Daniel Morgenstern; Kathy Pritchard-Jones; Tanzina Chowdhury
Journal:  Cancer Chemother Pharmacol       Date:  2016-02-13       Impact factor: 3.333

3.  Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

Authors:  Yves Daniel Compaoré; Issaka Zongo; Anyirékun F Somé; Nouhoun Barry; Frederick Nikiéma; Talato N Kaboré; Aminata Ouattara; Zachari Kabré; Kadidiatou Wermi; Moussa Zongo; Rakiswende S Yerbanga; Issaka Sagara; Abdoulaye Djimdé; Jean Bosco Ouédraogo
Journal:  Malar J       Date:  2021-01-29       Impact factor: 2.979

4.  To study the association between various levels of cord serum albumin (CSA) and significant neonatal hyperbilirubinemia requiring interventions like phototherapy or exchange transfusion.

Authors:  Apeksha Pathak; R Siddalingesha; Kamal N Prasad; Nibha Kamal; Archana Sinha; Ananya Ghosh; Bhuwan K Singh; Pankaj Kumar; R Surekha
Journal:  J Family Med Prim Care       Date:  2022-06-30

5.  Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial.

Authors:  Carlo Dani; Chiara Poggi; Fabio Mosca; Federico Schena; Gianluca Lista; Luca Ramenghi; Costantino Romagnoli; Enrica Salvatori; Maria Teresa Rosignoli; Paola Lipone; Alessandro Comandini
Journal:  Trials       Date:  2016-04-02       Impact factor: 2.279

6.  Association of cord serum albumin with neonatal hyperbilirubinemia among term appropriate-for-gestational-age neonates.

Authors:  Asit Kumar Mishra; C Sanyasi Naidu
Journal:  Int J Pediatr Adolesc Med       Date:  2018-12-13

7.  Exclusive dependence of IL-10Rα signalling on intestinal microbiota homeostasis and control of whipworm infection.

Authors:  María A Duque-Correa; Natasha A Karp; Catherine McCarthy; Simon Forman; David Goulding; Geetha Sankaranarayanan; Timothy P Jenkins; Adam J Reid; Emma L Cambridge; Carmen Ballesteros Reviriego; Werner Müller; Cinzia Cantacessi; Gordon Dougan; Richard K Grencis; Matthew Berriman
Journal:  PLoS Pathog       Date:  2019-01-14       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.